China is experiencing increased health care use and expenditures, without sufficient
controls to ensure quality and value.
Transparent, cost-conscious and patient-centered
guidelines based on the best available evidence could help establishing these quality
and practice measures.We examined how guidelines could support the Chinese health
reform. Specifically, we summarized the current state of the art and related challenges
in guideline development and explored possible solutions in the context of the Chinese
health reform.China currently lacks capacity for evidence-based guideline development
and coordination by a central agency. Most Chinese guideline users rely on recommendations
developed by professional groups that lack demonstration of transparency (including
conflict of interest management and evidence synthesis) and quality. These deficiencies
appear larger than in other regions of the world. In addition, misperceptions about
the role of guidelines in assisting practitioners as opposed to providing rules requiring
adherence, and a perception that traditional Chinese medicine (TCM) cannot be appropriately
incorporated in guidelines are present.China's capacity could be strengthened by a
central guideline agency to provide or coordinate evidence synthesis for guideline
development and to oversee the work of guideline developers. China can build on what
is known and work with the international community to develop methods to meet the
challenges of evidence-based guideline development.
Source: Health Research Policy and Systems
No comments:
Post a Comment
Add a comment